Table 1 Patient-related synoptical table
Patient | Gender | Age at FQA | Diagnosis | Prior surgery | Tumor origin | Staging at time of FQA | Pathological fracture | Indication | Treatment intention | Metastases before FQA | Local recurrence (months after FQA) | Follow-up (months) | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | m | 32 | es OS | y | st | II B | n | iT | c | n | 58 | 101 | AWD |
2 | f | 77 | OS | n | b | II B | n | iT | c | n | n | 3 | DOD |
3 | f | 72 | OS | y | b | II B | n | TR | c | n | n | 136 | NED |
4 | f | 19 | OS | y | b | III B | n | TR | c | y (lung) | n | 72 | DOD |
5 | m | 16 | OS | n | b | II B | y | iT | c | n | n | 132 | NED |
6 | m | 19 | OS | n | b | III B | y | iT | c | y (lung) | n | 2 | LOF |
7 | m | 55 | Lung cancer | n | b | Single bone metastasis | n | iT | c | y | n | 195 | NED |
8 | m | 19 | OS | y | b | III B | n | TR | c | y (lung) | n | 13 | DOD |
9 | f | 63 | DD CS | y | b | III B | y | iT | c | y (lymph node) | 2 | 60 | DOD |
10 | f | 64 | MFG G III | y | b | II B | n | TR | c | n | n | 5 | DOD |
11 | m | 32 | OS | n | b | II B | y | iT | c | n | n | 17 | DOD |
12 | f | 10 | OS | y | b | III B | y | iT | c | y (lung) | n | 109 | NED |
13 | f | 69 | NOS G III | n | st | II B | n | iT | c | n | n | 58 | NED |
14 | m | 57 | Liposarcoma G III | n | st | II B | n | iT | c | n | n | 38 | DOD |
15 | m | 32 | Hemagioendothelioma | y | b | II B | n | TR | c | n | n | 91 | NED |
16 | m | 43 | MFH G III | y | st | II B | n | TR | c | n | n | 8 | DOD |
17 | f | 35 | CS G III | n | b | II B | n | iT | c | n | n | 2 | LOF |
18 | f | 76 | MFH G III | y | st | II B | n | TR | c | n | 11 | 26 | DOD |
19 | m | 74 | Liposarcoma G III | y | st | II B | n | TR | c | n | n | 31 | DOD |
20 | m | 73 | CS G II | y | st | III B | n | TR | c | y (lymph node) | n | 25 | DOD |
21 | m | 66 | NOS G III | y | st | III B | n | TR | c | y (lung) | n | 41 | NED |
22 | f | 16 | OS | n | b | III B | y | iT | c | y (lung, bone) | n | 10 | DOD |
23 | m | 8 | OS | n | b | III B | y | iT | c | y (bone) | n | 9 | DOD |
24 | m | 37 | Fibrosarcoma G III | y | st | II B | n | TR | c | n | 4 | 18 | DOD |
25 | m | 76 | MFH G III | y | st | III B | n | TR | p | y (lung) | n | 19 | DOD |
26 | m | 74 | MFH G III | y | st | III B | n | TR | p | y (lung) | n | 15 | DOD |
27 | m | 83 | Squamous cell carcinoma | y | st | Multiple metastases | n | TR | p | y (lymph node, lung) | n | 1 | DOD |
28 | m | 53 | Synovial sarcoma G III | y | st | III B | n | TR | p | y (lung) | n | 21 | DOD |
29 | f | 70 | Merkel cell carcinoma | y | st | Multiple metastases | n | TR | p | y (lymph node) | n | 10 | DOD |
30 | m | 82 | Squamous cell carcinoma | y | st | Multiple metastases | n | TR | p | y (lymph node) | n | 17 | NED |